Arvind Remedies Ltd vs DIVI S LABORATORIES LTD

A side-by-side comparison of Arvind Remedies Ltd (ARVINDREM) and DIVI S LABORATORIES LTD (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads ARVINDREM vs DIVISLAB on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth10
  • Size & financial health03

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
95.04
0.00
P/B ratio
10.62
0.00%
Dividend yield
0.33%
₹-46.98
EPS
₹96.73

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-114.00%
Return on equity
16.50%
-9.00%
Return on capital
22.00%
-7.00%
EBITDA margin
33.00%
-40.66%
Net margin
24.32%

Growth

ARVINDREM takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

21.66%
Revenue CAGR (3Y)
10.78%
Profit CAGR (3Y) even
12.10%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹2.43L Cr
₹787 Cr
Revenue
₹10,560 Cr
₹-320 Cr
Net profit
₹2,568 Cr
0.00
Debt / equity even
0.00
Arvind Remedies Ltd
  • + ["Company has reduced debt."]
  • ["Company has low interest coverage ratio.", "Company has a low return on equity of -6.73% over last 3 years.", "Company has high debtors of 221 days.", "Company's cost of borrowing seems high"]
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Arvind Remedies Ltd full analysis DIVI S LABORATORIES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.